Mutational analysis of the estrogen receptor ligand-binding domain: Influence of ligand structure and stereochemistry on transactivation

被引:15
|
作者
Kohno, H
Bocchinfuso, WP
Gandini, O
Curtis, SW
Korach, KS
机构
[1] Lab. of Repro. and Devmtl. Toxicol., Natl. Inst. of Environ. Hlth. Sci., National Institutes of Health, Research Triangle Park, NC 27709
关键词
D O I
10.1677/jme.0.0160277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mouse estrogen receptor (mER) exhibits ligand stereochemical specificity for indenestrol A (IA), a stilbestrol estrogen. IA has a chiral C3 methyl group, and the mER preferentially binds the S-enantiomer (IA-S). resulting in elevated biological activity when compared with the IA-R enantiomer. To elucidate the mechanisms for this stereochemical recognition, we have constructed a series of mERs with individual amino acid substitutions at Met521, His528, Met532, and Val537. The abilities of yeast-expressed wild-type and mutant mERs to transactivate an estrogen-responsive reporter gene construct were measured in the presence of diethylstilbestrol (DES) and IA enantiomers. The concentration of IA-S required to induce half-maximal transactivation by wild-type mER was 10-fold lower than IA-R, which is attributed to the 15-fold greater binding affinity for IA-S. Wild-type mER displayed similar dose-response curves for IA-R and demethyl IA, which lacks a C3 methyl group, demonstrating that the presence and correct orientation of the C3 methyl group on the IA compound is required for high-affinity ligand binding and transcriptional activity. Each mutant exhibited a reduced preference for IA-S enantiomer with respect to transactivation, suggesting that this region of the mER functions in ligand stereochemical recognition and activation. A mutation at Met532 diminished DES- and IA-S-induced transactivation by 7.5-fold and 40-fold respectively, with minimal change on their binding affinity. These data suggest that Met532 is required for transactivation induced by the potent agonist, IA-S, and the M532G mutation effectively uncouples IA-S ligand binding from transactivation. Use of these stereochemically different ligands in combination with mutagenesis of the mER demonstrates that ligand structure could influence transactivation by specifically altering the conformation of the mER AF-2 region.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [21] The X-ray structure of a hemipteran ecdysone receptor ligand-binding domain - Comparison with a Lepidopteran ecdysone receptor ligand-binding domain and implications for insecticide design
    Carmichael, JA
    Lawrence, MC
    Graham, LD
    Pilling, PA
    Epa, VC
    Noyce, L
    Lovrecz, G
    Winkler, DA
    Pawlak-Skrzecz, A
    Eaton, RE
    Hannan, GN
    Hill, RJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (23) : 22258 - 22269
  • [22] LIGAND-BINDING AND HETERODIMERIZATION ACTIVITIES OF A CONSERVED REGION IN THE LIGAND-BINDING DOMAIN OF THE THYROID-HORMONE RECEPTOR
    SPANJAARD, RA
    DARLING, DS
    CHIN, WW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) : 8587 - 8591
  • [23] TRANSCRIPTIONAL ACTIVATION BY THE ESTROGEN-RECEPTOR REQUIRES A CONFORMATIONAL CHANGE IN THE LIGAND-BINDING DOMAIN
    BEEKMAN, JM
    ALLAN, GF
    TSAI, SY
    TSAI, MJ
    OMALLEY, BW
    MOLECULAR ENDOCRINOLOGY, 1993, 7 (10) : 1266 - 1274
  • [24] Utilizing the Estrogen Receptor Ligand-Binding Domain for Controlled Protein Translocation to the Insoluble Fraction
    Davis, James R.
    Mossalam, Mohanad
    Lim, Carol S.
    PHARMACEUTICAL RESEARCH, 2012, 29 (12) : 3455 - 3463
  • [25] Utilizing the Estrogen Receptor Ligand-Binding Domain for Controlled Protein Translocation to the Insoluble Fraction
    James R. Davis
    Mohanad Mossalam
    Carol S. Lim
    Pharmaceutical Research, 2012, 29 : 3455 - 3463
  • [26] Analysis of the ligand-binding domain of macrophage colony-stimulating receptor
    LUO Shouqing
    2. State Key Laboratory of Medicial Molecular Biology
    ChineseScienceBulletin, 2000, (13) : 1191 - 1195
  • [27] THE LIGAND-BINDING DOMAIN OF THE NICOTINIC ACETYLCHOLINE-RECEPTOR - IMMUNOLOGICAL ANALYSIS
    KACHALSKY, SG
    ALADJEM, M
    BARCHAN, D
    FUCHS, S
    FEBS LETTERS, 1993, 318 (03) : 264 - 268
  • [28] Synthesis and Crystal Structure of a Phosphorylated Estrogen Receptor Ligand Binding Domain
    Mocklinghoff, Sabine
    Rose, Rolf
    Carraz, Maelle
    Visser, Arie
    Ottmann, Christian
    Brunsveld, Luc
    CHEMBIOCHEM, 2010, 11 (16) : 2251 - 2254
  • [29] Structural analysis of sequence variants of the glucocorticoid receptor ligand-binding domain
    Likó, I
    Igaz, P
    Patócs, A
    Tóth, S
    Pázmány, T
    Tóth, M
    Rácz, K
    FEBS JOURNAL, 2005, 272 : 485 - 485
  • [30] Analysis of the ligand-binding domain of macrophage colony-stimulating receptor
    Luo, SQ
    Zheng, DX
    Liu, YX
    Rao, Q
    Wu, KF
    CHINESE SCIENCE BULLETIN, 2000, 45 (13): : 1191 - 1195